BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dhanasekaran R, Firpi RJ. Challenges of recurrent hepatitis C in the liver transplant patient. World J Gastroenterol 2014; 20(13): 3391-3400 [PMID: 24707122 DOI: 10.3748/wjg.v20.i13.3391]
URL: https://www.wjgnet.com/1007-9327/full/v20/i13/3391.htm
Number Citing Articles
1
Dame W. Idossa, Douglas Alano Simonetto. Infectious Complications and Malignancies Arising After Liver TransplantationAnesthesiology Clinics 2017; 35(3): 381 doi: 10.1016/j.anclin.2017.04.002
2
Gary C. Kanel. Atlas of Liver Pathology2024; : 445 doi: 10.1016/B978-0-323-82533-7.00013-2
3
Hyeyoung Kim, Kwang-Woong Lee, Nam-Joon Yi, Hae Won Lee, YoungRok Choi, Suk-Won Suh, Jaehong Jeong, Kyung-Suk Suh. Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver TransplantationJournal of Korean Medical Science 2015; 30(11): 1577 doi: 10.3346/jkms.2015.30.11.1577
4
Giovanna Russelli, Paola Pizzillo, Gioacchin Iannolo, Floriana Barbera, Fabio Tuzzolino, Rosa Liotta, Mario Traina, Giovanni Vizzini, Bruno Gridelli, Ester Badami, Pier Giulio Conaldi, Birke Bartosch. HCV replication in gastrointestinal mucosa: Potential extra-hepatic viral reservoir and possible role in HCV infection recurrence after liver transplantationPLOS ONE 2017; 12(7): e0181683 doi: 10.1371/journal.pone.0181683
5
Giada Pietrosi, Giovanna Russelli, Floriana Barbera, Gabriele Curcio, Fabio Tuzzolino, Alessia Gallo, Riccardo Volpes, Giovanni Vizzini, Pier Giulio Conaldi. Direct‐acting antivirals ability to clear intestinal HCV‐RNA in liver transplant patientsTransplant Infectious Disease 2020; 22(5) doi: 10.1111/tid.13345
6
Renumathy Dhanasekaran. Management of Immunosuppression in Liver TransplantationClinics in Liver Disease 2017; 21(2): 337 doi: 10.1016/j.cld.2016.12.007